VIMU
CVS icon

Veritas Investment Management (UK)’s CVS Health CVS Stock Holding History

Veritas Investment Management (UK)’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,750
Closed -$403K – 37
2021
Q3 		$403K Hold
4,750
– – 0.07% 28
2021
Q2 		$396K Buy
+4,750
New +$389K 0.07% 27
2019
Q2 		– Sell
-242,466
Closed -$13.1M – 36
2019
Q1 		$13.1M Sell
242,466
-6,472
-3% -$399K 4.06% 14
2018
Q4 		$16.3M Sell
248,938
-4,272
-2% -$319K 5.32% 9
2018
Q3 		$19.9M Buy
253,210
+19,187
+8% +$1.37M 5.49% 10
2018
Q2 		$15.1M Buy
234,023
+37,605
+19% +$2.48M 4.89% 12
2018
Q1 		$12.2M Buy
196,418
+8,404
+4% +$603K 4.15% 13
2017
Q4 		$13.6M Buy
188,014
+490
+0.3% +$35.6K 5.03% 10
2017
Q3 		$15.2M Buy
187,524
+2,420
+1% +$191K 5.37% 9
2017
Q2 		$14.9M Buy
185,104
+2,995
+2% +$236K 5.72% 8
2017
Q1 		$14.3M Buy
182,109
+7,085
+4% +$566K 5.52% 9
2016
Q4 		$13.8M Buy
175,024
+4,150
+2% +$336K 5.69% 9
2016
Q3 		$15.2M Buy
170,874
+235
+0.1% +$22.2K 7.36% 6
2016
Q2 		$16.3M Buy
170,639
+12,545
+8% +$1.25M 7.58% 4
2016
Q1 		$16.4M Buy
158,094
+16,620
+12% +$1.62M 8.18% 4
2015
Q4 		$13.8M Buy
141,474
+19,539
+16% +$1.91M 7.09% 4
2015
Q3 		$11.8M Buy
121,935
+72,555
+147% +$7.63M 7.36% 5
2015
Q2 		$5.18M Buy
49,380
+3,220
+7% +$329K 3.5% 10
2015
Q1 		$3.67M Buy
46,160
+38,620
+512% +$3.91M 2.74% 12
2014
Q4 		$600K Sell
7,540
-160
-2% -$14.1K 0.48% 29
2014
Q3 		$613K Sell
7,700
-64,010
-89% -$5.05M 0.45% 29
2014
Q2 		$5.37M Sell
71,710
-4,250
-6% -$321K 3.91% 8
2014
Q1 		$5.69M Buy
75,960
+3,440
+5% +$243K 4.14% 9
2013
Q4 		$5.19M Sell
72,520
-31,550
-30% -$2.03M 4.25% 7
2013
Q3 		$5.91M Sell
104,070
-30,260
-23% -$1.8M 4.87% 5
2013
Q2 		$7.68M Buy
+134,330
New +$7.78M 6.64% 4

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Veritas Investment Management (UK)'s CVS Position: Q4 2021 in Review

Veritas Investment Management (UK) sold out of CVS Health (CVS) in Q4 2021, closing a stake of 4,750 shares — an estimated $403K sold.

Veritas Investment Management (UK) first reported a position in CVS in Q2 2013 and held it in 26 quarters. The position peaked at $19.9M in Q3 2018. 2,343 funds tracked by Wall St. Rank hold CVS as of Q4 2021.

  • Veritas Investment Management (UK) reported no remaining CVS Health position as of Q4 2021 after selling out during the quarter.
  • Veritas Investment Management (UK) sold 4,750 CVS Health shares in Q4 2021, an estimated $403K.
  • Veritas Investment Management (UK) first reported a position in CVS Health in Q2 2013 and held it in 26 quarters.
  • Veritas Investment Management (UK)'s CVS Health position peaked at $19.9M in Q3 2018.
  • 2,343 funds tracked by Wall St. Rank held CVS Health as of Q4 2021.

Based on Veritas Investment Management (UK)'s 13F filing for Q4 2021, filed 11 Feb 2022.